In vivo, the flavanonol significantly reduced the growth of Ehrlich ascites carcinoma in mice and significantly lowered the plasma level of the vascular endothelial growth factor (VEGF) in tumor-bearing animals [101]. This evidence concerns the gene VEGFA and neoplasm.